Drug · CHEMBL55
PENTAMIDINE
7 sourcespipelines-2026-09-18-0.3.1
Cite this record
ConductScience Library. PENTAMIDINE. Drugs and targets, record CHEMBL55. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL55
On this page
Drug
Names and IDs as ChEMBL gives them, through Open Targets.
- Other names
- GNF-Pf-3680, MB 800 FREE BASE, MB-800, MB-800 (AS ISETHIONATE), MB-800 FREE BASE, Mp-601205, NSC-9921, Pentam 300, Pentamidina, RP 2512 FREE BASE, RP-2512, RP-2512 FREE BASE
- ChEMBL
Targets0
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
None in this release.
Diseases12
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
| Disease | Open Targets' stage | Stage reported by | Reports | Of them trials | Its drugs |
|---|---|---|---|---|---|
| pneumocystosis | Phase 3 | ClinicalTrials.gov | 6 | 6 | https://conductscience.org/library/drugs?q=MONDO_0019121 |
| AIDS | Phase 3 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0012268 |
| Lymphoma, AIDS-Related | Phase 2 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=EFO_1001365 |
| alcoholic fatty liver disease | Phase 1 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0021104 |
| aplastic anemia | Phase 2 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0015909 |
| classic Hodgkin lymphoma | Phase 1 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0009348 |
| cutaneous leishmaniasis | Phase 2 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0005446 |
| exocrine pancreatic carcinoma | Phase 1/2 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0005192 |
| hepatocellular carcinoma | Phase 1 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0007256 |
| human African trypanosomiasis | Phase 2 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0005459 |
1 to 10 of 12Source Open Targets
See all 12 diseasesTrials26
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.
| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT01360762 | Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study | Phase 3 | 74 | 2019-02-15 | pentamidine | Its name | ClinicalTrials.gov |
| NCT00944749 | Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment | Phase 2 | 23 | 2017-02-23 | pentamidine | Its name | ClinicalTrials.gov |
| NCT00729807 | 0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma | Phase 2 | 6 | 2016-10-21 | pentamidine | Its name | ClinicalTrials.gov |
| NCT00002340 | A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX | Phase 3 | 615 | pentamidine | Its name | ClinicalTrials.gov | |
| NCT00000991 | A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients | Phase 3 | 600 | pentamidine | Its name | ClinicalTrials.gov | |
| NCT07357103 | Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) | Phase 4 | 416 | pentamidine | Its name | ClinicalTrials.gov | |
| NCT00001028 | A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides | Phase 3 | 400 | pentamidine | Its name | ClinicalTrials.gov | |
| NCT00000727 | A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) | Phase 3 | 322 | pentamidine | Its name | ClinicalTrials.gov | |
| NCT00000715 | A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS | Phase 3 | 240 | pentamidine | Its name | ClinicalTrials.gov | |
| NCT00000730 | Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients | Phase 3 | 240 | pentamidine | Its name | ClinicalTrials.gov |
1 to 10 of 26
See all 26 trialsComparisons in its trials0
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
None in this release.
Papers from its trials10
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Tests in its trials0
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
None in this release.
Data dates
The date of each source this release read.
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this drug from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL55
GET https://conductscience.org/api/drugs/v1/CHEMBL55/trials?page=2